The serum levels of EA-IgA, Rta-IgG, VCA-IgA and P85-Ab were significantly lower in these patients than in those with newly diagnosed NPC (P < 0.0001 for all; Figure 2). The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.